Dr. David J. Kraman, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,002
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: Perelman School of Med at the University of Pennsylvania
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
PA license MD041913E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Temple University Hospital Philadelphia, PA
- Doylestown Hospital Doylestown, PA
- Jefferson Abington Hospital Abington, PA
- Jefferson Health- Northeast Philadelphia, PA
- Nazareth Hospital Philadelphia, PA
Medical groups
- Aria Health Physician Services (450 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,002
- Services billed
- 4,454
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 1,045 | 659 |
| Established patient office or other outpatient visit, 20-29 minutes | 693 | 507 |
| Ultrasound measurement of bladder capacity after voiding | 272 | 221 |
| Established patient office or other outpatient visit, 10-19 minutes | 224 | 210 |
| Established patient office or other outpatient visit, 30-39 minutes | 214 | 177 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 144 | 19 |
| Diagnostic exam of bladder and urethra using an endoscope | 114 | 92 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 91 | 65 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 47 | 47 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 42 | 42 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Philadelphia, PA | 1,084 |
| Finasteride Other prescribers in Philadelphia, PA | 363 |
| Myrbetriq (mirabegron) Other prescribers in Philadelphia, PA | 259 |
| Methenamine Hippurate Other prescribers in Philadelphia, PA | 175 |
| Cefuroxime (cefuroxime axetil) Other prescribers in Philadelphia, PA | 164 |
| Gemtesa (vibegron) Other prescribers in Philadelphia, PA | 137 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Philadelphia, PA | 94 |
| Ciprofloxacin Hcl Other prescribers in Philadelphia, PA | 88 |
| Silodosin Other prescribers in Philadelphia, PA | 84 |
| Dutasteride Other prescribers in Philadelphia, PA | 65 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 53 payments worth $3,473 in total to this clinician.
| Urogen Pharma, Inc. | $2,289 |
|---|---|
| Dentsply Ih Ab | $458 |
| Sumitomo Pharma America, Inc. | $304 |
| Astellas Pharma US Inc | $98.22 |
| Pfizer Inc. | $77.93 |
| Janssen Biotech, Inc. | $64.85 |
| Janssen Pharmaceuticals, Inc | $35.38 |
| Verity Pharmaceuticals Inc. | $34.69 |
| Consulting Fee | $1,875 |
|---|---|
| Food and Beverage | $1,598 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Urogen Pharma, Inc. Nov 10, 2025 | Consulting Fee | $1,875 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.